₹28 Cr
₹0 Cr
--
As on 03-Oct-2023 10:12 IST
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vanta Bioscience
| -30.87 | -- | -0.14 | -48.08 | -38.58 | -12.09 | -- |
|
S&P BSE Commodities
| 2.32 | -0.32 | 5.59 | 8.40 | 27.45 | 14.05 | -- |
|
S&P BSE Small Cap
| 30.66 | 1.00 | 15.93 | 32.84 | 36.17 | 21.30 | 21.27 |
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|
|
Vanta Bioscience
| -49.78 | -3.24 | 17.23 | 33.49 | 28.26 |
|
S&P BSE Small Cap
| -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
S&P BSE Commodities
| 1.22 | 61.53 | 26.07 | -4.62 | -19.21 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
No Review & Analysis are available.
The total asset value of Vanta Bioscience Ltd. stood at ₹ 70 Cr as on 31-Mar-21
The share price of Vanta Bioscience Ltd. is ₹44.00 (BSE) as of 03-Oct-2023 10:12 IST. Vanta Bioscience Ltd. has given a return of -38.58% in the last 3 years.
Vanta Bioscience Ltd. has a market capitalisation of ₹ 28 Cr as on 03-Oct-2023. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Vanta Bioscience Ltd. is 1.16 times as on 03-Oct-2023, a -0.74% premium to its peers’ median range of 4.54 times.
Since, TTM earnings of Vanta Bioscience Ltd. is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vanta Bioscience Ltd. and enter the required number of quantities and click on buy to purchase the shares of Vanta Bioscience Ltd..
Research and experimental development on natural sciences and engineering
The prominent promoters of Vanta Bioscience Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
MOHAN KRISHNA MULAKALA |
55.22%
|
|
DOPESH RAJA MULAKALA |
7.26%
|
|
S CHANDRA SEKHAR RAO |
1.94%
|
|
SOUMYA SIMHADRI |
1.43%
|
The chairman of the company is Mohan Krishna Mulakala, and the managing director is Dopesh Raja Mulakala.
The promoters of Vanta Bioscience Ltd. have pledged 0% of the total equity as on Mar-23.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
8,182
|
|
|
6,096
|
|
|
5,519
|
|
|
4,500
|
| Vanta Bioscience Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
1.89
|
|
Return on capital employed(%)
|
5.42
|
|
Debt-to-equity ratio
|
1.5
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Vanta Bioscience Ltd. was ₹0 Cr.
No Review & Analysis are available.
₹27.77 Cr
₹9.82 Cr
₹0.45 Cr
₹2.65 Cr
₹35.97 Cr
69.36%
Low
₹39.90 - 84.55
₹10.00
63,12,000
BSE: 540729
Hyderabad, Telangana
www.vantabio.com
Research and experimental development on natural sciences and engineering
Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.
Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.
Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.
Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.
Share via Facebook 
Share via Twitter 
Share via LinkedIn 
Share this
Add Portfolio 